iBio, Inc.
(NYSE Amex Equities : IBIO)

( )
IBIO After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Biotechnology
GILDGilead Sciences, Inc. 0.80%63.941.0%$481.30m
AMGNAmgen, Inc. -0.72%235.041.3%$433.22m
BIIBBiogen, Inc. -1.35%284.211.4%$384.69m
ILMNIllumina, Inc. -1.21%327.003.5%$329.26m
VRTXVertex Pharmaceuticals, Inc. -0.30%233.911.9%$282.39m
REGNRegeneron Pharmaceuticals, Inc. -0.71%356.602.6%$239.03m
EXASEXACT Sciences Corp. -2.93%92.1824.0%$232.61m
ALXNAlexion Pharmaceuticals, Inc. -2.56%108.552.0%$173.61m
INCYIncyte Corp. -0.31%78.242.5%$131.13m
AAgilent Technologies, Inc. -1.23%89.021.6%$127.01m
SRPTSarepta Therapeutics, Inc. -3.93%113.6814.6%$110.30m
BMRNBioMarin Pharmaceutical, Inc. -2.24%85.634.3%$107.80m
SGENSeattle Genetics, Inc. 3.27%115.356.1%$99.56m
BLUEbluebird bio, Inc. -4.35%89.7214.2%$89.98m
DERMDermira, Inc. -0.37%18.763.8%$83.55m

Company Profile

iBio, Inc. is a biotechnology company, which engages in the development and manufacture of biotherapeutics. Its pipeline include idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. It operates through the iBio, Inc. and iBio CDMO business segments. The company was founded on April 15, 1993 and is headquartered in New York, NY.